{"id":78782,"date":"2026-03-24T00:05:16","date_gmt":"2026-03-24T00:05:16","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/"},"modified":"2026-03-24T00:05:16","modified_gmt":"2026-03-24T00:05:16","slug":"inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/","title":{"rendered":"Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results  \u00a0"},"content":{"rendered":"<div>\n<p align=\"justify\"><b>Daix (France), New York (United States), March 23, 2026\u00a0<\/b>\u2013 <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=r2EvvE1c3d0YEFhUARHZQzx5iKAVubBGQ3Pkll_cgfU-ca1OPMIXFzroqg57NM87kvpwvAKI8ER4C4NyGKTtA3B8DfK3cJ2eqGpTpDHqwOUeoFzuwor2pejXsK0WRHsIJ6O0x7x3I2sMWUhiHFzqs3c0YyuzrVDAZOYQfoBe4gkvAvaj68hSM2jzM5GzMt62\" rel=\"nofollow\" target=\"_blank\" title=\"Inventiva\">Inventiva<\/a> (Euronext Paris and NASDAQ: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sEjzIYADVQv1bLggJYn3f5t_Fcg_vk2B7O7VYkSBAUFN4Qjgie1UH-TJDGkSLlV9TrrEFk6cAuibdt6SVdOmDN9rZpOAjhWtAIbyRnE0nWWlRcgcA-SXC7dH2_eST9k8USIyOaMY_eMNosqq90O4f9UDu1Lgtv7z6CbyaoWLGtA=\" rel=\"nofollow\" target=\"_blank\" title=\"IVA\">IVA<\/a>) (\u201cInventiva\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (\u201cMASH\u201d), today announced that it will release its 2025 full-year financial results on Monday, March 30, 2026, after market close in the United States.<\/p>\n<p align=\"justify\">Inventiva\u2019s management will hold a conference call in English, followed by a Q&amp;A session, <b>on Tuesday, March 31, 2026, at 8:00 am (New York), 2:00 pm (Paris)<\/b>.<\/p>\n<p align=\"justify\">Participants wishing to join the conference call by phone and ask questions must register in advance <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YXdywqhCmzDR9jNvRiWpQzpaAw2W3lG00yNZy8zfg_pedgxJDbK0lOpQpOm8qZlXvfXxkzxQuc7XPnHVuyQok4iPmcd0ZvwsvjZjNoKGP5NGSuM1aYLRp88Aa4QMD2UemR0Hx8xxqeWP5P9AMUAnm3x6Vtnr955TouryR_T1K2ULM4HJ-I6OMDSKQ7jF-lI3KUCW2MaJLhNrR_FGGyCW7l16qrndFU4IUAfErMD6OH6aADo0tF3p1_So2a_PQzvgmZFQm4VQ-jk6G_Q8CGo_FKxSpdXm0aOvAPDYAvLZHR9lh-tCTot0FT0v-Jhmr2-Zz6o7EAM0R7tviZOifEJUlDp3Ar_euJ9v7riu9uGmg09cHXMo5aPuMsHbqHZiN6Y6NccRHBfjfZyKNfDpafz_XM70MB39yf60DVN7FrKKLV_9Tq4g6tvqJg6VERxtBan7XXl9tsCIhuRYRbZbm2LgZEEoinWT8xOGnqrJ-T4S-9lL7ADeScV6WAB7pRMBGhc6w8jL7bjtzgDM3eAOlDY-uPJMLEHAOGo0Mmp8EGjo91BbRwJnnQDm9j0ijilsgVCPwQbHhs9ABVUYsZ-ZlO9U3rbq6v6GR1PnbdczhrzrWQyauI_-ZgUWeilIZh18WgnOgaB5eRLivpnxIXSFs3uLpq14MVp2vHK3uM1OKPPeWUMCWsVX3WMLL0JkReahhF3u53WTCImNhnR8ftNpVOfisw==\" rel=\"nofollow\" target=\"_blank\" title=\"here\">here<\/a>. Upon registration, participants will receive dial-in details by email.<\/p>\n<p align=\"justify\">The live webcast may be accessed at the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=r2EvvE1c3d0YEFhUARHZQzdizpOiY0QLw17VDFIW-Z73FzJXKiz4woOSKg_rPiZt1qTrT_vHlRmnIZd0Au9dAjwuVoJ3W9mQ9MZOnIhVUZgSqQ6u0AyTruvnhdeF_6D5s-E0W-yBEgledvTudxzDubOJPEINylnwDP_xIkZIt6w=\" rel=\"nofollow\" target=\"_blank\" title=\"Investors Presentations\">Investors Presentations<\/a> section of the Inventiva website.<\/p>\n<p align=\"justify\">A replay of the conference call will be available after the event on the Company\u2019s <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vdZqce-dK7ArxjfGiguDra1_SRw0hyowH3q5Ue4BsmX-0pdhn7b1n2qgY3HlF_szZ4CduyYsg2LJGAxCsaBcoo44SGYbLLkYeFfghARr0Brkf9dlfrNwJ7XhZdC82b2ORuaH8jDf-cN_BvrzrLyxaw==\" rel=\"nofollow\" target=\"_blank\" title=\"website\">website<\/a>.<\/p>\n<p align=\"justify\"><b>About Inventiva\u00a0<\/b><\/p>\n<p align=\"justify\">Inventiva is a clinical-stage biopharmaceutical company focused on the research and development of oral small molecule therapies for the treatment of patients with MASH and other diseases with significant unmet medical need. The Company is currently evaluating lanifibranor, a novel pan-PPAR agonist, in the NATiV3 pivotal Phase 3 clinical trial for the treatment of adult patients with MASH, a common and progressive chronic liver disease.<\/p>\n<p>Inventiva is a public company listed on compartment B of the regulated market of Euronext Paris (ticker: IVA, ISIN: FR0013233012) and on the Nasdaq Global Market in the United States (ticker: IVA). <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1ZYP149bafm23n3Wqptz2YqmtSviYl0hal-LxYuQUpYzDprSXbzwcWHc1KsxU-uzNtw9rAEJ2EVOWugf-pBq6aF29lNkdML_a0LWKxbSxyYbDQorsk4ooJsPNoZ1bdeg\" rel=\"nofollow\" target=\"_blank\" title=\"\">http:\/\/www.inventivapharma.com<\/a><\/p>\n<p><b>Contacts <\/b><\/p>\n<table style=\"border-collapse: collapse; width:661px; border-collapse:collapse ;\">\n<tr>\n<td style=\"width:347px;;vertical-align: middle;   text-align: left;   padding-left: 20.0px; vertical-align: middle;   text-align: left;   padding-left: 20.0px; vertical-align: top ; \"><b>Investor Relations<\/b><br \/>David Nikodem: <a href=\"mailto:IR@inventivapharma.com\" rel=\"nofollow\" target=\"_blank\" title=\"IR@inventivapharma.com\">IR@inventivapharma.com<\/a><br \/>Patricia L. Bank: <a href=\"mailto:patti.bank@icrhealthcare.com\" rel=\"nofollow\" target=\"_blank\" title=\"patti.bank@icrhealthcare.com\">patti.bank@icrhealthcare.com<\/a><\/td>\n<td style=\"width:314px;;vertical-align: middle;   text-align: left;   padding-left: 20.0px; vertical-align: middle;   text-align: left;   padding-left: 20.0px; vertical-align: top ; \"><b>Media Relations<\/b><br \/>Pascaline Clerc: <a href=\"mailto:media@inventivapharma.com\" rel=\"nofollow\" target=\"_blank\" title=\"media@inventivapharma.com\">media@inventivapharma.com<\/a><br \/>Alexis Feinberg: <a href=\"mailto:inventivapr@icrhealthcare.com\" rel=\"nofollow\" target=\"_blank\" title=\"inventivapr@icrhealthcare.com\">inventivapr@icrhealthcare.com<\/a><\/td>\n<\/tr>\n<\/table>\n<p id=\"gnw_attachments_section-header\">\n    <strong>Attachment<\/strong>\n<\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n        <a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=rGlyCdZz7n1-MG7y4latijmxvgyqUJ12Cd6MVzkqQe1RAPLlDKX9thO25vNJKBULOVslWoqkuut-qQDfErVLWlZYvyVTcdA0bZQbgT96r5krLFUumh9oiH-4nPYqPEs15FMNNuZCrsaR-FKOfN8lSpMgXevtQOd2j_ZKTAcCzBfAbQE75OSvuQXPAHjjGmpxQuFRxtocbm3ykfZKJRNadzOUe2MtOZSydOSwJUR2tQw=\" title=\"Inventiva - PR - FY 2025 Results Webcast - EN - 03 23 2026\" rel=\"nofollow\">Inventiva &#8211; PR &#8211; FY 2025 Results Webcast &#8211; EN &#8211; 03 23 2026<\/a>\n      <\/li>\n<\/ul>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/NTY3ODE0NDUtNzMzMi00MTdjLThkZGQtZWRiODdmNjgwMGY3LTEwOTM4MjAtMjAyNi0wMy0yMy1lbg==\/tiny\/INVENTIVA.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Daix (France), New York (United States), March 23, 2026\u00a0\u2013 Inventiva (Euronext Paris and NASDAQ: IVA) (\u201cInventiva\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (\u201cMASH\u201d), today announced that it will release its 2025 full-year financial results on Monday, March 30, 2026, after [&#8230;]\n","protected":false},"author":1,"featured_media":85254,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-78782","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results \u00a0 - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results \u00a0\" \/>\n<meta property=\"og:description\" content=\"Daix (France), New York (United States), March 23, 2026\u00a0\u2013 Inventiva (Euronext Paris and NASDAQ: IVA) (\u201cInventiva\u201d or the \u201cCompany\u201d), a clin\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-24T00:05:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml-eu.globenewswire.com\/media\/NTY3ODE0NDUtNzMzMi00MTdjLThkZGQtZWRiODdmNjgwMGY3LTEwOTM4MjAtMjAyNi0wMy0yMy1lbg==\/tiny\/INVENTIVA.png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results \u00a0\",\"datePublished\":\"2026-03-24T00:05:16+00:00\",\"dateModified\":\"2026-03-24T00:05:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/\"},\"wordCount\":291,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/\",\"name\":\"Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results \u00a0 - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-03-24T00:05:16+00:00\",\"dateModified\":\"2026-03-24T00:05:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results \u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results \u00a0 - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results \u00a0","og_description":"Daix (France), New York (United States), March 23, 2026\u00a0\u2013 Inventiva (Euronext Paris and NASDAQ: IVA) (\u201cInventiva\u201d or the \u201cCompany\u201d), a clin","og_url":"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-03-24T00:05:16+00:00","og_image":[{"url":"https:\/\/ml-eu.globenewswire.com\/media\/NTY3ODE0NDUtNzMzMi00MTdjLThkZGQtZWRiODdmNjgwMGY3LTEwOTM4MjAtMjAyNi0wMy0yMy1lbg==\/tiny\/INVENTIVA.png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results \u00a0","datePublished":"2026-03-24T00:05:16+00:00","dateModified":"2026-03-24T00:05:16+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/"},"wordCount":291,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/","url":"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/","name":"Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results \u00a0 - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-03-24T00:05:16+00:00","dateModified":"2026-03-24T00:05:16+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/inventiva-schedules-the-publication-and-presentation-of-its-2025-full-year-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results \u00a0"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/78782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=78782"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/78782\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/85254"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=78782"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=78782"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=78782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}